SCHEMBL21358264

SCHEMBL21358264

COC(Cl)(Br)Cc1cncnc1N

nearest known ligand 0.38

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
TKT P29401 1/20 0.38
DGAT1 O75907 1/20 0.33
P2RX3 P56373 1/20 0.32
P2RX2 Q9UBL9 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12776166 0.75 DGAT1 (0.42) TKTDGAT1
SCHEMBL27928345 0.72 TKT (0.40) TKTDGAT1
SCHEMBL30338990 0.69 TKT (0.41) TKTDGAT1P2RX3P2RX2
SCHEMBL12877696 0.69
SCHEMBL11319147 0.69
SCHEMBL317516 0.67
SCHEMBL12844554 0.66 TKT (0.44) TKTDGAT1
SCHEMBL317515 0.65
SCHEMBL7118818 0.65
SCHEMBL12862586 0.65 TKT (0.40) TKTDGAT1P2RX3P2RX2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019177375-A1 2, 4, 5-SUBSTITUTED PYRIMIDINE DERIVATIVES, METHOD FOR PREPARING SAME, AND PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CANCER COMPRISING SAME AS ACTIVE INGREDIENT 포로노이바이오 주식회사 2019-09-19 WO disclosed